| 10556907 |
Fused heterocyclic compounds as S1P modulators |
Udo Lange, Michael Ochse, Elizabeth Louise VAN DER KAM, Jeroen VAN BERGEIJK, Sean Colm Turner +6 more |
2020-02-11 |
$392,529,000 |
| 10308610 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Jurgen Dinges, Clarissa Jakob |
2019-06-04 |
$590,682,000 |
| 10280159 |
Fused (hetero)cyclic compounds as S1P modulators |
Wilhelm Amberg, Udo Lange, Michael Ochse, Ralf Biesinger, Frank Oellien |
2019-05-07 |
$328,740,000 |
| 10160744 |
Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
Andreas Haupt, Frauke Pohlki, Ana-Lucia Relo, Liliane Unger, Karsten Wicke |
2018-12-25 |
|
| 9938269 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Berthold Behl, Loic Laplanche, Jurgen Dinges +2 more |
2018-04-10 |
$908,521,000 |
| 9862704 |
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases |
Wilfried Hornberger, Charles W. Hutchins, Katja Jantos, Andreas Kling, Loic Laplanche +1 more |
2018-01-09 |
$640,201,000 |
| 9856220 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Jurgen Dinges, Clarissa Jakob |
2018-01-02 |
$106,945,000 |
| 9840495 |
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases |
Wilfried Hornberger, Charles W. Hutchins, Katja Jantos, Andreas Kling, Loic Laplanche +1 more |
2017-12-12 |
$208,732,000 |
| 9790203 |
Inhibitor compounds of phosphodiesterase type 10A |
Sean Colm Turner, Michael Ochse, Karla Drescher, Lawrence A. Black, Katja Jantos |
2017-10-17 |
$801,857,000 |
| 9688678 |
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases |
Wilfried Hornberger, Katja Jantos, Andreas Kling, Marcel van Gaalen |
2017-06-27 |
$159,595,000 |
| 9657034 |
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors |
Michael Ochse, Karla Drescher, Sean Colm Turner, Berthold Behl, Loic Laplanche +4 more |
2017-05-23 |
|
| 9657002 |
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases |
Katja Jantos, Wilfred Braje, Andreas Kling, Liliane Unger, Berthold Behl +4 more |
2017-05-23 |
$153,003,000 |
| 9617226 |
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases |
Wilfried Braje, Jayne Froggett, Wilfried Hornberger, Katja Jantos, Andreas Kling +1 more |
2017-04-11 |
$236,573,000 |
| 9527856 |
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases |
Wilfried Braje, Wilfried Hornberger, Katja Jantos, Andreas Kling, Claudia Krack +1 more |
2016-12-27 |
$303,958,000 |
| 9487505 |
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
Wilfried Lubisch, Wilfried Hornberger, Thorsten Oost, Daryl Sauer, Liliane Unger +1 more |
2016-11-08 |
$206,870,000 |
| 9475808 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Berthold Behl, Loic Laplanche, Jurgen Dinges +1 more |
2016-10-25 |
$312,321,000 |
| 9464085 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Clarissa Jakob |
2016-10-11 |
$171,188,000 |
| 9422264 |
Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
Astrid Netz, Thorsten Oost, Wilfried Braje, Wolfgang Wernet, Liliane Unger +2 more |
2016-08-23 |
$746,833,000 |
| 9403796 |
Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
Thorsten Oost, Astrid Netz, Wilfried Braje, Wolfgang Wernet, Liliane Unger +2 more |
2016-08-02 |
$193,125,000 |
| 9388180 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Clarissa Jakob, Maricel Torrent |
2016-07-12 |
$246,047,000 |
| 9273036 |
Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases |
Katja Jantos, Wilfred Braje, Andreas Kling, Liliane Unger, Berthold Behl +4 more |
2016-03-01 |
$121,077,000 |
| 9273068 |
Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Sean Colm Turner, Berthold Behl, Loic Laplanche +3 more |
2016-03-01 |
$121,077,000 |
| 9242933 |
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) |
Daryl Sauer, Wilfried Braje, Wilhelm Amberg, Mario Mezler, Margaretha Henrica Maria Bakker |
2016-01-26 |
$303,602,000 |
| 9200005 |
Inhibitor compounds of phosphodiesterase type 10A |
Katja Jantos, Michael Ochse, Jayne Froggett, Clarissa Jakob, Karla Drescher +1 more |
2015-12-01 |
$100,538,000 |
| 9163019 |
Inhibitor compounds of phosphodiesterase type 10A |
Michael Ochse, Karla Drescher, Berthold Behl, Loic Laplanche, Jurgen Dinges +1 more |
2015-10-20 |
$87,093,000 |
